Lexaria Bioscience receives HREC approval for Phase 1b DehydraTECH GLP-1 study
Lexaria Bioscience (LEXX) has received lead clinical site human research ethics committee approval that was required before dosing can begin in ...
Lexaria announces partial 12-week blood sugar results from GLP-1 diabetes study
Lexaria Bioscience (LEXX) received partial 12-week blood sugar results from the recently completed animal study WEIGHT-A24-1. The company said, ...
SheKnows3y
Dr. Lexx Brown-James
The stories you care about, delivered daily.
Hempnewsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Engages CRO For Dehydratech GLP-1 Human Study
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced it has hired a contract research organiza ...
Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria ...